Related Experiment Videos
Carbamazepine lithium combination for lithium resistant mania
N G Desai1, C Andrade, B N Gangadhar
1Department of Psychiatry, NIMHANS, Bangalore.
Indian Journal of Psychiatry
|September 20, 2011
Summary
This study shows that combining lithium and carbamazepine is an effective treatment for mania in patients who do not respond to lithium alone. This combination also offers significant prophylactic benefits with minimal side effects.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Lithium is a first-line treatment for bipolar disorder, but some patients exhibit non-response.
- Carbamazepine is an alternative mood stabilizer with a different mechanism of action.
Purpose of the Study:
- To evaluate the therapeutic and prophylactic efficacy of lithium-carbamazepine combination in lithium non-responders with mania.
- To assess the safety profile of this combined treatment.
Main Methods:
- An open prospective trial was conducted.
- Five cases of mania, identified as lithium non-responders, were treated with the lithium-carbamazepine combination.
Main Results:
- The lithium-carbamazepine combination demonstrated therapeutic effectiveness in managing manic episodes.
- Prophylactic efficacy was observed, indicating a reduction in future episodes.
- The treatment was well-tolerated, with no significant adverse side effects reported.
Conclusions:
- The combination of lithium and carbamazepine is a viable and effective strategy for treating mania in lithium non-responders.
- This combination offers both acute and long-term mood stabilization benefits.
- Further research into combination therapies for bipolar disorder is warranted.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:30Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...